http://mises.org/community/forums/197.aspxPolitics, disasters, war and peace.enCommunityServer 2008.5 SP2 (Build: 40407.4157)http://mises.org/community/forums/thread/505085.aspxMon, 19 Nov 2012 20:07:17 GMT944abf2b-d1be-4bf2-990d-438cb0e377e9:505085Al_Gore the Idiot0http://mises.org/community/forums/thread/505085.aspxhttp://mises.org/community/forums/commentrss.aspx?SectionID=197&PostID=505085<p> We claim:<br /> <br /> 1. A method of treating diseases caused by oxidative stress, comprising administering a therapeutically effective amount of a cannabinoid that has substantially no binding to the NMDA receptor to a subject who has a disease caused by oxidative stress.</p> <p> ...</p><div style="clear:both;"></div>http://mises.org/community/forums/thread/502553.aspxWed, 07 Nov 2012 18:30:11 GMT944abf2b-d1be-4bf2-990d-438cb0e377e9:502553Al_Gore the Idiot0http://mises.org/community/forums/thread/502553.aspxhttp://mises.org/community/forums/commentrss.aspx?SectionID=197&PostID=502553<p> <font size="+1">Cannabinoids as antioxidants and neuroprotectants </font></p> <b>Abstract</b> <p> Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. <span style="background-color:#ffff00;">This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer&#39;s disease, Parkinson&#39;s disease and HIV dementia.</span> Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH.sub.3, and COCH.sub.3. ##STR1##</p> <p> <span style="background-color:#ffff00;">Assignee: </span><b><span style="background-color:#ffff00;">The United States of America as represented by the Department of Health and Human Services</span></b> (Washington, DC)</p> <p> &nbsp;</p> <p> <img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/f/f0/US-patent-6630507.pdf/page1-408px-US-patent-6630507.pdf.jpg" /></p><div style="clear:both;"></div>